Orphan drug status granted to sirolimus OSN SuperSite The US Food and Drug Administration granted orphan drug designation to sirolimus (DE-109) for the treatment of chronic/refractory anterior noninfectious uveitis, noninfectious intermediate uveitis, noninfectious panuveitis and noninfectious uveitis ... Santen Sirolimus drug secures FDA orphan drug status Santen Announces FDA Orphan Drug Status for Sirolimus (DE-109) |
